Second-Generation Sequencing for Cancer Genome Analysis

作者: Hye-Jung E. Chun , Jaswinder Khattra , Martin Krzywinski , Samuel A. Aparicio , Marco A. Marra

DOI: 10.1016/B978-0-12-396967-5.00002-5

关键词:

摘要: Cancer results from accumulated mutations in the genome. Sequencing is an accurate method to detect mutations. Second-generation sequencing technology, commonly referred as next-generation enables rapid, efficient and affordable DNA sequencing, transforming scale scope of cancer research. The technology sufficiently flexible allow many genomes, thus facilitates both samples large patient cohorts during disease progression individual patients. high depths redundant sequence coverage that can be obtained using some second-generation technologies, along with reads amplified single molecules, facilitate detection subclones cells tumors. Large-scale genome hundreds or even thousands being conducted by several groups aim identify characterize driver Goals such work, previously infeasible Sanger instruments, are use this information improve prognosis, diagnosis therapeutic decision-making. speed data analysis rate limiting, investigators struggling accommodate interpret deluge produced technologies. In chapter, we discuss properties revealed implication experimental design interpretation. We describe past, current upcoming technologies application genomics. Finally, impact shaping personalized medicine.

参考文章(123)
Narayana Battula, Lawrence A. Loeb, Clark F. Springgate, Errors in DNA Replication as a Basis of Malignant Changes Cancer Research. ,vol. 34, pp. 2311- 2321 ,(1974)
Thomas Ernst, Andrew J Chase, Joannah Score, Claire E Hidalgo-Curtis, Catherine Bryant, Amy V Jones, Katherine Waghorn, Katerina Zoi, Fiona M Ross, Andreas Reiter, Andreas Hochhaus, Hans G Drexler, Andrew Duncombe, Francisco Cervantes, David Oscier, Jacqueline Boultwood, Francis H Grand, Nicholas C P Cross, Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Nature Genetics. ,vol. 42, pp. 722- 726 ,(2010) , 10.1038/NG.621
Fatih Ozsolak, Adam R. Platt, Dan R. Jones, Jeffrey G. Reifenberger, Lauryn E. Sass, Peter McInerney, John F. Thompson, Jayson Bowers, Mirna Jarosz, Patrice M. Milos, Direct RNA sequencing Nature. ,vol. 461, pp. 814- 818 ,(2009) , 10.1038/NATURE08390
Matthew Meyerson, Stacey Gabriel, Gad Getz, Advances in understanding cancer genomes through second-generation sequencing Nature Reviews Genetics. ,vol. 11, pp. 685- 696 ,(2010) , 10.1038/NRG2841
P. Nowell, The clonal evolution of tumor cell populations Science. ,vol. 194, pp. 23- 28 ,(1976) , 10.1126/SCIENCE.959840
Anton Nekrutenko, James Taylor, None, Next-generation sequencing data interpretation: enhancing reproducibility and accessibility Nature Reviews Genetics. ,vol. 13, pp. 667- 672 ,(2012) , 10.1038/NRG3305
Jay Shendure, Erez Lieberman Aiden, The expanding scope of DNA sequencing Nature Biotechnology. ,vol. 30, pp. 1084- 1094 ,(2012) , 10.1038/NBT.2421
Sarah B. Ng, Emily H. Turner, Peggy D. Robertson, Steven D. Flygare, Abigail W. Bigham, Choli Lee, Tristan Shaffer, Michelle Wong, Arindam Bhattacharjee, Evan E. Eichler, Michael Bamshad, Deborah A. Nickerson, Jay Shendure, Targeted capture and massively parallel sequencing of 12 human exomes Nature. ,vol. 461, pp. 272- 276 ,(2009) , 10.1038/NATURE08250
Siân Jones, Tian-Li Wang, Ie-Ming Shih, Tsui-Lien Mao, Kentaro Nakayama, Richard Roden, Ruth Glas, Dennis Slamon, Luis A. Diaz, Bert Vogelstein, Kenneth W. Kinzler, Victor E. Velculescu, Nickolas Papadopoulos, Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma Science. ,vol. 330, pp. 228- 231 ,(2010) , 10.1126/SCIENCE.1196333